Clotrimazole, but not dexamethasone, is a potent in vitro inhibitor of cytochrome P450 isoforms CYP1A and CYP3A in rainbow trout

Chemosphere

Volumn 92, Issue 9, 2013, Pages 1099-1104

  Burkina, Viktoriia ^a   Zlabek, Vladimir ^a   Zamaratskaia, Galia ^b  

^a UNIVERSITY OF SOUTH BOHEMIA   (Czech Republic)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Clotrimazole; CYP1A; CYP2E1 like protein; CYP3A; Dexamethasone; Rainbow trout

Indexed keywords

BIOCHEMISTRY;

CLOTRIMAZOLE; CYP1A; CYP3A; DEXAMETHASONES; RAINBOW TROUT;

PROTEINS;

CLOTRIMAZOLE; CYTOCHROME P450 1A; CYTOCHROME P450 3A; DEXAMETHASONE;

CONCENTRATION (COMPOSITION); CYTOCHROME; DRUG; ENZYME ACTIVITY; INHIBITION; INHIBITOR; METABOLISM; PROTEIN; SALMONID; SUBSTRATE; XENOBIOTICS;

ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; IN VITRO STUDY; LIVER MICROSOME; MALE; NONHUMAN; RAINBOW TROUT;

ONCORHYNCHUS MYKISS;

EID: 84880315103     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2013.01.050     Document Type: Article

References (49)

1. Ayub M., Levell M.J. Structure-activity relationships of the inhibition of human placental aromatase by imidazole drugs including ketoconazole. J. Steroid. Biochem. 1988, 31:65-72.
2. Baudiffier D., Hinfray N., Vosges M., Creusot N., Chadili E., Porcher J.M., Schulz R.W., Brion F. A critical role of follicle-stimulating hormone (Fsh) in mediating the effect of clotrimazole on testicular steroidogenesis in adult zebrafish. Toxicology 2012, 298:30-39.
3. Beausse J. Selected drugs in solid matrices: a review of environmental determination, occurrence and properties of principal substances. Trac-Trend. Anal. Chem. 2004, 23:753-761.
4. Burkina V., Zamaratskaia G., Randak T., Li Z.H., Fedorova G., Pickova J., Zlabek V. Verapamil does not modify catalytic activity of CYP450 in rainbow trout after long-term exposure. Ecotoxicol. Environ. Saf. 2012, 79:148-152.
5. Caro A., Cederbaum A.I. Oxidative stress, toxicology, and pharmacology of CYP2E1. Annu. Rev. Pharmacol. Toxicol. 2004, 44:27-42.
6. Cheshenko K., Pakdel F., Segner H., Kah O., Eggen R.I.L. Interference of endocrine disrupting chemicals with aromatase CYP19 expression or activity, and consequences for reproduction of teleost fish. Gen. Comp. Endocrinol. 2008, 155:31-62.
7. Christen V., Caminada D., Arand M., Fent K. Identification of a CYP3A form (CYP3A126) in fathead minnow (Pimephales promelas) and characterisation of putative CYP3A enzyme activity. Anal. Bioanal. Chem. 2010, 396:585-595.
8. Corcoran J., Winter M.J., Tyler C.R. Pharmaceuticals in the aquatic environment: A critical review of the evidence for health effects in fish. Crit. Rev. Toxicol. 2010, 40:287-304.
9. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 2006, 76:122-159.
10. Geter D.R., Fournie J.W., Brouwer M.H., DeAngelo A.B., Hawkins W.E. P-Nitrophenol and glutathione response in medaka (Oryzias latipes) exposed to MX, a drinking water carcinogen. Comp. Biochem. Physiol. C 2003, 134:353-364.
11. Hasler J.A., Estabrook R., Murray M., Pikuleva I., Waterman M., Capdevila J., Holla V., Helvig C., Falck J.R., Farrell G., Kaminsky L.S., Spivack S.D., Boitier E., Beaune P. Human cytochromes P450. Mol. Aspects. Med. 1999, 20:1-137.
12. Havelkova M., Randak T., Zlabek V., Krijt J., Kroupova H., Pulkrabova J., Svobodova Z. Biochemical markers for assessing aquatic contamination. Sensors 2007, 7:2599-2611.
13. Hegelund T., Celander M.C. Hepatic versus extrahepatic expression of CYP3A30 and CYP3A56 in adult killifish (Fundulus heteroclitus). Aquat. Toxicol. 2003, 64:277-291.
14. Hinfray N., Porcher J.M., Brion F. Inhibition of rainbow trout (Oncorhynchus mykiss) P450 aromatase activities in brain and ovarian microsomes by various environmental substances. Comp. Biochem. Physiol. C 2006, 144:252-262.
15. Hinfray N., Baudiffier D., Leal M.C., Porcher J.M., Ait-Aissa S., Le Gac F., Schulz R.W., Brion F. Characterization of testicular expression of P450 17 alpha-hydroxylase, 17,20-lyase in zebrafish and its perturbation by the pharmaceutical fungicide clotrimazole. Gen. Comp. Endocrinol. 2011, 174:309-317.
16. Hirakawa I., Miyagawa S., Katsu Y., Kagami Y., Tatarazako N., Kobayashi T., Kusano T., Mizutani T., Ogino Y., Takeuchi T., Ohta Y., Iguchi T. Gene expression profiles in the testis associated with testis-ova in adult Japanese medaka (Oryzias latipes) exposed to 17α-ethinylestradiol. Chemosphere 2012, 87:668-674.
17. Hockey B., Leslie K., Williams D. Dexamethasone for intracranial neurosurgery and anesthesia. J. Clin. Neurosci. 2009, 16:1389-1393.
18. Husoy A.M., Myers M.S., Willis M.L., Collier T.K., Celander M., Goksoyr A. Immunohistochemical localization of CYP1A-like and CYP3A-like isozymes in hepatic and extrahepatic tissues of Atlantic cod (Gadus morhua L), a marine fish. Toxicol. Appl. Pharm. 1994, 129:294-308.
19. Kugathas S., Williams R.J., Sumpter J.P. Prediction of environmental concentrations of glucocorticoids: The River Thames, UK, as an example. Environ. Int. 2012, 40:15-23.
20. Laville N., Ait-Aissa S., Gomez E., Casellas C., Porcher J.M. Effects of human pharmaceuticals on cytotoxicity, EROD activity and ROS production in fish hepatocytes. Toxicology 2004, 196:41-55.
21. Levine S.L., Oris J.T. Noncompetitive mixed-type inhibition of rainbow trout CYP1A catalytic activity by clotrimazole. Comp. Biochem. Physiol. C 1999, 122:205-210.
22. Levine S.L., Oris J.T., Denison M.S. Modulation of CYP1A expression in rainbow trout by a technical grade formulation of propiconazole. Environ. Toxicol. Chem. 1999, 18:2565-2573.
23. Li D., Yang X.L., Zhang S.J., Lin M., Yu W.J., Hu K. Effects of mammalian CYP3A inducers on CYP3A-related enzyme activities in grass carp (Ctenopharyngodon idellus): Possible implications for the establishment of a fish CYP3A induction model. Comp. Biochem. Physiol. C 2008, 147:17-29.
24. Li Z.H., Zlabek V., Velisek J., Grabic R., Machova J., Kolarova J., Li P., Randak T. Acute toxicity of carbamazepine to juvenile rainbow trout (Oncorhynchus mykiss): Effects on antioxidant responses, hematological parameters and hepatic EROD. Ecotoxcol. Environ. Saf. 2011, 74:319-327.
25. Liska D., Lyon M., Jones D.S. Detoxification and biotransformational imbalances. Explore-NY. 2006, 2:122-140.
26. Liu S., Ying G.G., Zhao J.L., Chen F., Yang B., Zhou L.J., Lai H.J. Trace analysis of 28 steroids in surface water, wastewater and sludge samples by rapid resolution liquid chromatography-electrospray ionization tandem mass spectrometry. J. Chromatogr. A 2011, 1218:1367-1378.
27. Lu C., Li A.P. Species comparison in P450 induction: effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog. Chem-Biol. Interact. 2001, 134:271-281.
28. Miranda C.L., Henderson M.C., Buhler D.R. Evaluation of chemicals as inhibitors of trout cytochrome P450s. Toxicol. Appl. Pharm. 1998, 148:237-244.
29. Monod G., Demones A., Fostier A. Inhibition of ovarian microsomal aromatase and follicular estradiol secretion by imidazole fungicides in rainbow-trout. Mar. Environ. Res. 1993, 35:153-157.
30. Navas J.M., Chana A., Herradon B., Segner H. Induction of cytochrome P4501A (CYP1A) by clotrimazole, a non-planar aromatic compound. Computational studies on structural features of clotrimazole and related imidazole derivatives. Life Sci. 2004, 76:699-714.
31. Peschka M., Roberts P.H., Knepper T.P. Analysis, fate studies and monitoring of the antifungal agent clotrimazole in the aquatic environment. Anal. Bioanal. Chem. 2007, 389:959-968.
32. Relling M.V., Nemec J., Schuetz E.G., Schuetz J.D., Gonzalez F.J., Korzekwa K.R. O-Demethylation of Epipodophyllotoxins is catalyzed by human cytochrome P450 3A4. Mol. Pharmacol. 1993, 45:352-358.
33. Ringel M., Oesch F., Gerl M., Klebach M., Quint M., Bader A., Bottger T., Hengstler J.G. Permissive and suppressive effects of dexamethasone on enzyme induction in hepatocyte co-cultures. Xenobiotica 2002, 32:653-666.
34. Rozman D., Waterman M.R. Lanosterol 14a-demethylase (CYP51) and spermatogenesis. Drug. Metab. Dispos. 1998, 26:1199-1201.
35. Schwaiger J., Ferling H., Mallow U., Wintermayr H., Negele R.D. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac Part 1: histopathological alterations and bioaccumulation in rainbow trout. Aquat. Toxicol. 2004, 68:141-150.
36. Shapiro L.E., Shear N.H. Drug interactions: proteins, pumps, and P-450s. J. Am. Acad. Dermatol. 2002, 47:467-484.
37. Smith E.M., Wilson J.Y. Assessment of cytochrome P450 fluorometric substrates with rainbow trout and killifish exposed to dexamethasone, pregnenolone-16 alpha-carbonitrile, rifampicin, and beta-naphthoflavone. Aquat. Toxicol. 2010, 97:324-333.
38. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 1985, 150:76-85.
39. Snegaroff J., Bach J. Effects of the fungicide prochloraz on xenobiotic metabolism in rainbow-trout - inhibition in vitro and time course of induction in vivo. Xenobiotica 1989, 19:255-267.
40. Stresser D.M., Blanchard A.P., Turner S.D., Erve J.C.L., Dandeneau A.A., Miller V.P., Crespi C.L. Substrate-dependent modulation of CYP3A4 catalytic activity: Analysis of 27 test compounds with four fluorometric substrates. Drug Metab. Dispos. 2000, 28:1440-1448.
41. Tassaneeyakul W., Birkett D.L., Miners J.O. Inhibition of human hepatic cytochrome P4502E1 by azole antifungals, CNS-active drugs and nonsteroidal anti-inflammatory agents. Xenobiotica 1998, 28:293-301.
42. Tomlinson E.S., Lewis D.F.V., Maggs J.L., Kroemer H.K., Park B.K., Back D.J. In vitro metabolism of dexamethasone (DEX) in human liver and kidney: the involvement of CYP3A4 and CYP17 (17, 20 LYASE) and molecular modelling studies. Biochem. Pharmacol. 1997, 54:605-611.
43. Trosken E.R., Fischer K., Volkel W., Lutz W.K. Inhibition of human CYP19 by azoles used as antifungal agents and aromatase inhibitors, using a new LC-MS/MS method for the analysis of estradiol product formation. Toxicology 2006, 219:33-40.
44. Uno T., Ishizuka M., Itakura T. Cytochrome P450 (CYP) in fish. Environ. Toxicol. Pharmocol. 2012, 34:1-13.
45. van der Oost R., Beyer J., Vermeulen N.P.E. Fish bioaccumulation and biomarkers in environmental risk assessment: a review. Environ. Toxicol. Pharmacol. 2003, 13:57-149.
46. Vane J., Botting R. Inflammation and the mechanism of action of anti-inflammatory drugs. FASEB J. 1987, 1:89-96.
47. Zamaratskaia G., Zlabek V. EROD and MROD as markers of cytochrome P450 1A activities in hepatic microsomes from entire and castrated male pigs. Sensors 2009, 9:2134-2147.
48. Zamaratskaia G., Zlabek V. Para-nitrophenol hydroxylation by fish liver microsomes: kinetics and effect of selective cytochrome P450 inhibitors. Fish Physiol. Biochem. 2011, 37:969-976.
49. Zlabek V., Zamaratskaia G. Comparison of three fluorescent CYP3A substrates in two vertebrate models: pig and Atlantic salmon. Animal 2012, 6:633-640.